STOCK TITAN
  1. Home
  2. Sec-filings
  3. ALGS
  4. [Form 4] Aligos Therapeutics, Inc. Insider Trading Activity

[Form 4] Aligos Therapeutics, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary
Analyzing...
Positive
  • None.
Negative
  • None.

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Stock ALGS logo
Aligos Therapeutics, Inc.

NASDAQ:ALGS

ALGS Rankings

#7096 Ranked by Market Cap
N/A Ranked by Dividends

ALGS Latest News

Jul 11, 2025
Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Jun 18, 2025
Aligos Therapeutics Appoints Kieron Wesson as Vice President, Head of Chemistry Manufacturing Controls (CMC)
Jun 13, 2025
Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 29, 2025
Aligos Therapeutics to Present at the Jefferies Global Healthcare Conference
May 20, 2025
Aligos Therapeutics Appoints Laura Kavanaugh as Vice President, Head of Legal

ALGS Latest SEC Filings

Jul 18, 2025
[Form 4] Aligos Therapeutics, Inc. Insider Trading Activity
Jul 18, 2025
[Form 4] Aligos Therapeutics, Inc. Insider Trading Activity
Jun 26, 2025
[Form 4] Aligos Therapeutics, Inc. Insider Trading Activity
Jun 26, 2025
[Form 4] Aligos Therapeutics, Inc. Insider Trading Activity
Jun 26, 2025
[Form 4] Aligos Therapeutics, Inc. Insider Trading Activity

ALGS Stock Data

53.75M
4.76M
11.58%
34.03%
20.13%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States
SOUTH SAN FRANCISCO